Page last updated: 2024-11-07

spironolactone and Hematemesis

spironolactone has been researched along with Hematemesis in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Hematemesis: Vomiting of blood that is either fresh bright red, or older coffee-ground in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mackay, A1
Stevenson, RD1

Other Studies

1 other study available for spironolactone and Hematemesis

ArticleYear
Gastric ulceration induced by spironolactone.
    Lancet (London, England), 1977, Feb-26, Volume: 1, Issue:8009

    Topics: Ascites; Female; Hematemesis; Humans; Middle Aged; Peptic Ulcer Hemorrhage; Spironolactone; Stomach

1977